168 related articles for article (PubMed ID: 173959)
1. Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.
McElroy FA; Philip RB
Life Sci; 1975 Nov; 17(9):1479-93. PubMed ID: 173959
[No Abstract] [Full Text] [Related]
2. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
Asano T; Ochiai Y; Hidaka H
Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
[No Abstract] [Full Text] [Related]
3. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
4. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
Hidaka H; Asano T
J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
[TBL] [Abstract][Full Text] [Related]
5. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
Agarwal KC; Buckley RS; Parks RE
Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
7. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.
Stefanovich V
Arzneimittelforschung; 1975 May; 25(5):740-1. PubMed ID: 170944
[TBL] [Abstract][Full Text] [Related]
9. The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.
Rozenberg MC; Walker CM
Br J Haematol; 1973 Apr; 24(4):409-18. PubMed ID: 4351761
[No Abstract] [Full Text] [Related]
10. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood.
Patterson WD; Hardman JG; Sutherland EW
Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831
[TBL] [Abstract][Full Text] [Related]
11. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
Asano T; Hidaka H
Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
Beretz A; Briançon-Scheid F; Stierlé A; Corre G; Anton R; Cazenave JP
Biochem Pharmacol; 1986 Jan; 35(2):257-62. PubMed ID: 3002388
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
14. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
Manns JM; Brenna KJ; Colman RW; Sheth SB
Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the immune response to sheep erythrocytes in mice by phosphodiesterase-inhibiting dipyridamole derivatives.
Lichtner R; Wedderburn N
J Immunopharmacol; 1984; 6(1-2):43-55. PubMed ID: 6088639
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol, on platelet and vascular cyclooxygenase activity.
De La Cruz JP; Ortega G; Sánchez de la Cuesta F
Biochem Pharmacol; 1994 Jan; 47(2):209-15. PubMed ID: 8304965
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
[No Abstract] [Full Text] [Related]
18. Mode of action of dipyridamole on human platelets.
Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG
Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583
[No Abstract] [Full Text] [Related]
19. Inhibitors of cyclic nucleotide phosphodiesterases inhibit protein carboxyl methylation in intact blood platelets.
Macfarlane DE
J Biol Chem; 1984 Jan; 259(2):1357-62. PubMed ID: 6198323
[TBL] [Abstract][Full Text] [Related]
20. Hemorrheologic effects of pyrimido-pyrimidine derivatives.
Ambrus JL; Stadler I; Kulaylat M; Koreshi A; Akhtar S
J Med; 1996; 27(1-2):21-32. PubMed ID: 8863175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
